Regulation of ligands for the NKG2D activating receptor

DH Raulet, S Gasser, BG Gowen… - Annual review of …, 2013 - annualreviews.org
NKG2D is an activating receptor expressed by all NK cells and subsets of T cells. It serves
as a major recognition receptor for detection and elimination of transformed and infected …

Metalloproteinases and their natural inhibitors in inflammation and immunity

R Khokha, A Murthy, A Weiss - Nature Reviews Immunology, 2013 - nature.com
Over the past 50 years, steady growth in the field of metalloproteinase biology has shown
that the degradation of extracellular matrix components represents only a fraction of the …

Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity

L Ferrari de Andrade, RE Tay, D Pan, AM Luoma, Y Ito… - Science, 2018 - science.org
MICA and MICB are expressed by many human cancers as a result of cellular stress, and
can tag cells for elimination by cytotoxic lymphocytes through natural killer group 2D …

NKG2D and its ligands:“one for all, all for one”

A Zingoni, R Molfetta, C Fionda, A Soriani… - Frontiers in …, 2018 - frontiersin.org
The activating receptor NKG2D is peculiar in its capability to bind to numerous and highly
diversified MHC class I-like self-molecules. These ligands are poorly expressed on normal …

Leveraging NKG2D ligands in immuno-oncology

MB Fuertes, CI Domaica, NW Zwirner - Frontiers in Immunology, 2021 - frontiersin.org
Immune checkpoint inhibitors (ICI) revolutionized the field of immuno-oncology and opened
new avenues towards the development of novel assets to achieve durable immune control …

ADAM17: a molecular switch to control inflammation and tissue regeneration

J Scheller, A Chalaris, C Garbers, S Rose-John - Trends in immunology, 2011 - cell.com
A disintegrin and metalloproteinase 17 (ADAM17), also known as tumor necrosis factor-α
converting enzyme (TACE), is a membrane-bound enzyme that cleaves cell surface …

Overcoming resistance to natural killer cell based immunotherapies for solid tumors

G Nayyar, Y Chu, MS Cairo - Frontiers in oncology, 2019 - frontiersin.org
Despite advances in the diagnostic and therapeutic modalities, the prognosis of several
solid tumor malignancies remains poor. Different factors associated with solid tumors …

Effect of NKG2D ligand expression on host immune responses

M Champsaur, LL Lanier - Immunological reviews, 2010 - Wiley Online Library
Natural killer group 2, member D (NKG2D) is an activating receptor present on the surface of
natural killer (NK) cells, some NKT cells, CD8+ cytotoxic T cells, γδ T cells, and under certain …

Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens

RW Childs, M Carlsten - Nature reviews Drug discovery, 2015 - nature.com
Scientific insights into the human immune system have recently led to unprecedented
breakthroughs in immunotherapy. In the twenty-first century, drugs and cell-based therapies …

Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA* 008 that is shed by tumor cells in exosomes

O Ashiru, P Boutet, L Fernández-Messina… - Cancer research, 2010 - AACR
The MHC class I–related chain (MIC) A and MICB ligands for the activating receptor NKG2D
can be shed from tumor cells, and the presence of these soluble molecules in sera is related …